California Public Employees Retirement System Boosts Position in Phibro Animal Health Corp (PAHC)

California Public Employees Retirement System increased its position in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 7.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 38,619 shares of the company’s stock after buying an additional 2,723 shares during the period. California Public Employees Retirement System’s holdings in Phibro Animal Health were worth $1,778,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of PAHC. Segall Bryant & Hamill LLC acquired a new position in Phibro Animal Health during the second quarter valued at approximately $21,724,000. BlackRock Inc. boosted its position in Phibro Animal Health by 7.7% during the second quarter. BlackRock Inc. now owns 3,304,441 shares of the company’s stock valued at $152,169,000 after purchasing an additional 235,932 shares during the last quarter. Renaissance Technologies LLC boosted its position in Phibro Animal Health by 18.2% during the second quarter. Renaissance Technologies LLC now owns 634,500 shares of the company’s stock valued at $29,219,000 after purchasing an additional 97,700 shares during the last quarter. Granite Investment Partners LLC boosted its position in Phibro Animal Health by 43.8% during the second quarter. Granite Investment Partners LLC now owns 312,978 shares of the company’s stock valued at $14,413,000 after purchasing an additional 95,308 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its position in Phibro Animal Health by 10.2% during the second quarter. Fuller & Thaler Asset Management Inc. now owns 346,664 shares of the company’s stock valued at $15,964,000 after purchasing an additional 32,214 shares during the last quarter. Institutional investors and hedge funds own 47.55% of the company’s stock.

In other news, VP Daniel M. Bendheim sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $44.30, for a total value of $110,750.00. Following the completion of the sale, the vice president now directly owns 2,500 shares of the company’s stock, valued at $110,750. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jack Bendheim sold 30,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $50.20, for a total value of $1,506,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 183,020 shares of company stock valued at $9,049,971. Insiders own 50.29% of the company’s stock.

PAHC has been the subject of several recent research reports. BidaskClub raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, August 8th. Zacks Investment Research raised Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Thursday, August 30th. Morgan Stanley increased their price target on Phibro Animal Health from $36.00 to $46.00 and gave the company an “underweight” rating in a research report on Wednesday, August 29th. Finally, Barclays increased their price target on Phibro Animal Health from $31.00 to $33.00 and gave the company an “underweight” rating in a research report on Thursday, July 5th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $43.20.

Shares of NASDAQ PAHC opened at $42.29 on Friday. Phibro Animal Health Corp has a 52 week low of $32.05 and a 52 week high of $54.62. The company has a quick ratio of 1.66, a current ratio of 2.90 and a debt-to-equity ratio of 1.62. The company has a market cap of $1.74 billion, a P/E ratio of 24.69, a P/E/G ratio of 3.61 and a beta of 0.91.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Monday, August 27th. The company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.42 by $0.04. Phibro Animal Health had a return on equity of 39.81% and a net margin of 7.90%. The firm had revenue of $211.80 million during the quarter, compared to analysts’ expectations of $209.27 million. During the same period in the prior year, the firm posted $0.39 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts anticipate that Phibro Animal Health Corp will post 1.75 EPS for the current year.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: What are the most popular ETFs

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply